Loading...
Loading...
Browse all stories on DeepNewz
VisitWhich major pharmaceutical company will announce a psilocybin-based treatment by Dec 31, 2024?
Johnson & Johnson • 25%
Pfizer • 25%
Novartis • 25%
Other • 25%
Company press releases and official websites
Psilocybin in Magic Mushrooms Disrupts Brain Networks, Causes Lasting Changes
Jul 17, 2024, 03:14 PM
New research published in Nature reveals that psilocybin, the active compound in magic mushrooms, disrupts the brain's default mode network, leading to a psychedelic experience. The study, which involved brain imaging and a randomized trial with fMRI in healthy participants, found that a large dose of psilocybin causes profound and widespread desynchronization of brain activity. This disruption affects entire networks of neurons responsible for controlling a person’s sense of time and self. The findings also indicate that psilocybin can influence brain communication pathways for weeks, causing lasting changes in how distinct brain regions connect.
View original story
Pfizer • 25%
Johnson & Johnson • 25%
Merck • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Novartis • 25%
Roche • 25%
Yes • 50%
No • 50%
Depression • 25%
Anxiety • 25%
PTSD • 25%
Other • 25%
Yes • 50%
No • 50%
United States • 25%
Canada • 25%
United Kingdom • 25%
Australia • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Merck • 25%
Other • 25%
Johnson & Johnson • 25%
Merck • 25%
AstraZeneca • 25%
Other • 25%
Pfizer • 25%
Roche • 25%
Novartis • 25%
Other • 25%
AbbVie • 25%
Bristol Myers Squibb • 25%
Another major pharmaceutical company • 25%
No new approvals • 25%
Yes • 50%
No • 50%
Other • 25%
USA • 25%
Canada • 25%
Germany • 25%
Other • 25%
Depression • 25%
Anxiety • 25%
PTSD • 25%